<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01421836</url>
  </required_header>
  <id_info>
    <org_study_id>2011-03-101-001</org_study_id>
    <nct_id>NCT01421836</nct_id>
  </id_info>
  <brief_title>Prospective Study Comparing EUS vs ERCP Stent Insertion for Malignant Biliary Obstruction</brief_title>
  <official_title>Prospective Study Comparing EUS Guided Biliary Drainage and ERCP With Stent Placement for Malignant Biliary Obstruction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. Purpose of the study

           -To compare stent patency and complication rate between endoscopic ultrasound (EUS)
           guided stent insertion and endoscopic retrograde cholangiopancreatography (ERCP) guided
           stent insertion for malignant biliary obstruction

        2. Subjects of the study

           -Patients who have biliary obstruction owing to malignant tumors

        3. Methods of the study

             -  Prospective randomized controlled study

             -  Patients were enrolled randomly in two groups, EUS guided stent insertion group or
                ERCP guided stent insertion group

             -  Patients will get assigned procedure (EUS guided stent insertion or ERCP guided
                stent insertion)for decompression of malignant biliary obstruction

             -  After the procedure, regular follow up, blood test,and imaging test will be done to
                check sufficient biliary decompression,stent patency and complications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Inclusion criteria 1) age: 18 - 80 2) a patients who had common bile duct dilatation
           because of malignant distal common bile duct obstruction in radiologically 3)
           Hyperbilirubinemia (total bilirubin &gt;= 1.5 mg/dl) 4) inoperable state 5) a patients who
           agree to join this study

        2. Exclusion criteria 1) a patients who can not endure sedation 2) a patients with bleeding
           tendency (PT &gt; 1.5 INR, PLT &lt; 50,000) 3) a patients with systemic infection 4) a
           patients who had hilar obstruction
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>stent patency (days)</measure>
    <time_frame>six months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>complication rate</measure>
    <time_frame>six months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Tumor Appearance of Biliary System Obstruction</condition>
  <arm_group>
    <arm_group_label>ERCP guided stent insertion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>EUS guided stent insertion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ERCP-guided stent insertion</intervention_name>
    <description>ERCP guided stent insertion for malignant biliary obstruction</description>
    <arm_group_label>ERCP guided stent insertion</arm_group_label>
    <other_name>ERCP-guided metal stent insertion</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>EUS guided stent insertion</intervention_name>
    <description>EUS-guided stent insertion for malignant biliary obstruction</description>
    <arm_group_label>EUS guided stent insertion</arm_group_label>
    <other_name>EUS-guided metal stent insertion</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  distal biliary obstruction due to malignant tumor

          -  unresectable tumor

          -  Jaundice

        Exclusion Criteria:

          -  Children

          -  Hilar obstruction

          -  Active infection

          -  Bleeding tendency
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kwanghyuck Lee, MD, phD</last_name>
    <role>Study Director</role>
    <affiliation>Division of Gastroenterology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <state>Irwon-dong, Gangnam-gu</state>
        <zip>135-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 22, 2011</study_first_submitted>
  <study_first_submitted_qc>August 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 23, 2011</study_first_posted>
  <last_update_submitted>April 27, 2016</last_update_submitted>
  <last_update_submitted_qc>April 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Samsung Medical Center</investigator_affiliation>
    <investigator_full_name>Kwang Hyuck Lee</investigator_full_name>
    <investigator_title>Professor of Department of Medicine,Samsung Medical Center,Sungkyunkwan University School of Medicine</investigator_title>
  </responsible_party>
  <keyword>stent patency</keyword>
  <keyword>EUS guided insertion</keyword>
  <keyword>ERCP guided insertion</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

